Aloka to buy Ecotron Holding

Article

Ultrasound vendor Aloka of Tokyo last month agreed to purchase its European distributor, Ecotron Holding of Zug, Switzerland. The deal, valued at about $3.5 million and subject to Ecotron shareholder approval, will create a sales, marketing, and customer

Ultrasound vendor Aloka of Tokyo last month agreed to purchase its European distributor, Ecotron Holding of Zug, Switzerland. The deal, valued at about $3.5 million and subject to Ecotron shareholder approval, will create a sales, marketing, and customer support operation called Aloka Holding (Europe). The firms hoped to complete the merger last month.

Aloka's purchase of Ecotron covers Ecotron's sales and service assets, including divisions in France, Italy, and Spain. All 70 Ecotron employees will be absorbed into the new firm, and its distributor network across Eastern Europe will be restructured. Roberto Bucciarelli, president and CEO of Ecotron, will become president of Aloka Holding (Europe). With the acquisition, Aloka will increase its access to the European market, according to Masayuki Kai, Aloka president. Aloka posts worldwide revenues of about $350 million.

Recent Videos
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Can AI Assessment of Longitudinal MRI Scans Improve Prediction for Pediatric Glioma Recurrence?
A Closer Look at MRI-Guided Adaptive Radiotherapy for Monitoring and Treating Glioblastomas
Incorporating CT Colonography into Radiology Practice
What New Research Reveals About Computed Tomography and Radiation-Induced Cancer Risk
What New Interventional Radiology Research Reveals About Treatment for Breast Cancer Liver Metastases
New Mammography Studies Assess Image-Based AI Risk Models and Breast Arterial Calcification Detection
Can Deep Learning Provide a CT-Less Alternative for Attenuation Compensation with SPECT MPI?
Employing AI in Detecting Subdural Hematomas on Head CTs: An Interview with Jeremy Heit, MD, PhD
Pertinent Insights into the Imaging of Patients with Marfan Syndrome
Related Content
© 2025 MJH Life Sciences

All rights reserved.